Loading clinical trials...
Loading clinical trials...
This is a double-blind, randomized, multicenter, phase 3 clinical trial to compare the efficacy and safety of brentuximab vedotin in combination with CHP with the standard-of-care CHOP in patients wit...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Seagen Inc.
Collaborators
NCT06390319 · T-cell Acute Lymphoblastic Leukemia, T-cell Lymphoma, and more
NCT03922724 · Peripheral T-cell Lymphomas, Lymphoproliferative Disorders, and more
NCT07249528 · Non-hodgkin Lymphoma, Multiple Myeloma
NCT06386315 · Indolent B-Cell Non-Hodgkin Lymphoma, Recurrent Indolent B-Cell Non-Hodgkin Lymphoma, and more
NCT03223610 · Lymphoma, Non-Hodgkin Lymphoma, and more
Banner MD Anderson Cancer Center
Gilbert, Arizona
City of Hope National Medical Center
Duarte, California
Stanford Cancer Center
Stanford, California
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions